MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 25 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,754,000 | -46.8% | 3,392,136 | -43.5% | 0.07% | -72.7% |
| Q1 2021 | $20,220,000 | +10712.8% | 6,000,000 | +3244.1% | 0.26% | +5020.0% |
| Q1 2020 | $187,000 | -68.2% | 179,419 | 0.0% | 0.01% | -58.3% |
| Q4 2019 | $588,000 | +10.1% | 179,419 | 0.0% | 0.01% | -14.3% |
| Q3 2019 | $534,000 | +18.1% | 179,419 | 0.0% | 0.01% | +40.0% |
| Q2 2019 | $452,000 | – | 179,419 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,029,649 | $12,331,000 | 0.54% |
| Vivo Capital, LLC | 778,000 | $2,381,000 | 0.17% |
| Logos Global Management LP | 200,000 | $612,000 | 0.12% |
| DAFNA Capital Management LLC | 76,800 | $235,000 | 0.07% |
| Verition Fund Management LLC | 395,290 | $1,210,000 | 0.04% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 250,000 | $765,000 | 0.02% |
| CSS LLC/IL | 54,773 | $168,000 | 0.01% |
| Point72 Asset Management, L.P. | 375,000 | $1,148,000 | 0.01% |
| Marshall Wace North America L.P. | 267,180 | $818,000 | 0.01% |
| HHLR ADVISORS, LTD. | 124,970 | $382,000 | 0.00% |